CODEXIS INC. - COMMON STOCK

Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development

15 Nov 2021 07:00:03 By Nasdaq GlobeNewswire

Codexis to Present Data Highlighting Two New Therapeutic Discovery Programs at the 14th International Congress of Inborn Errors of Metabolism 2021

15 Nov 2021 07:00:03 By Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

09 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

Codexis Reports Third Quarter 2021 Financial Results

04 Nov 2021 15:05:02 By Nasdaq GlobeNewswire

The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc.

04 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

Codexis and Nestlé Health Science Initiate a Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

03 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

Codexis to Report Third Quarter 2021 Financial Results on November 4

21 Oct 2021 15:05:00 By Nasdaq GlobeNewswire

Codexis, Almelo and RC2 Announce a Tri-Party Collaboration for the Enzymatic Production of Low Cost Sitagliptin API for the Generic Market, Including a License to Codexis Enzyme Technology in India

18 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin

09 Sep 2021 15:05:00 By Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

07 Sep 2021 15:05:00 By Nasdaq GlobeNewswire

Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global Pharmaceutical Company

25 Aug 2021 15:05:00 By Nasdaq GlobeNewswire

Codexis Reports Second Quarter 2021 Financial Results

05 Aug 2021 15:05:03 By Nasdaq GlobeNewswire

Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage Ingredient

02 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage Ingredient

26 Jul 2021 15:05:00 By Nasdaq GlobeNewswire

Codexis to Report Second Quarter 2021 Financial Results on August 5

22 Jul 2021 15:05:01 By Nasdaq GlobeNewswire

Codexis Announces Completion of CodeEvolver® License Technology Transfer with Global Pharmaceutical Leader

14 Jul 2021 15:05:00 By Nasdaq GlobeNewswire

Codexis Earns Milestone Payment from GlaxoSmithKline

07 Jul 2021 15:05:00 By Nasdaq GlobeNewswire

Codexis Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme Product

17 Jun 2021 15:44:08 By Nasdaq GlobeNewswire

Codexis and Takeda Expand Strategic Collaboration and License Agreement to Discover Additional Gene Therapy for a Fourth Rare Genetic Disorder

10 Jun 2021 06:00:00 By Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

25 May 2021 15:05:00 By Nasdaq GlobeNewswire